Document is current
Any future updates will be listed below
-
Authors
Marquié, Marta
Verwer, Eline E.
Meltzer, Avery C.
Kim, Sally Ji Who
Agüero, Cinthya
Gonzalez, Jose
Makaretz, Sara J.
Siao Tick Chong, Michael
Ramanan, Prianca
Amaral, Ana C.
Normandin, Marc D.
Vanderburg, Charles R.
Gomperts, Stephen N.
Johnson, Keith A.
Frosch, Matthew P.
Gómez-Isla, Teresa https://orcid.org/0000-0002-7977-2075
-
Funding
Funding for this research was provided by:
ASISA Foundation, Madrid, Spain
Society of Nuclear Medicine and Molecular Imaging Education and Research Foundation
National Institutes of Health (T32EB013180)
International Health Central America Institute, San Jose, Costa Rica
NIH National Institute of Neurological Disorders and Stroke (U01NS086659)
NIH National Institute of Mental Health (R01MH100350)
NIH National Institute for Neurological Disorders and Stroke (R21 NS090243)
National Parkinson's Foundation
Michael J. Fox Foundation for Parkinson's Research
National Institutes of Health (R01 EB014894, R01 AG026484, R01 AG034556, P50 AG00513421, P01 AG036694, U19 AG10483, R13 AG042201174210, R01 AG027435)
National Institutes of Health (R21 AG038994)
National Institutes of Health (R01 AG037497)
Alzheimer’s Association (ZEN-10-174210K)
Massachusetts Alzheimer´s Disease Research Center (AG005134)
NIH National Institute on Aging (AG005134, AG036694)
- License Information
-
More Information
Article History
Received: 11 October 2017
Accepted: 11 October 2017
First Online: 19 October 2017
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments.
: Informed consent was obtained from all individual participants included in the study and according to institutional procedures for autopsy consents for post-mortem tissue.
: Marta Marquié received research funding from the ASISA foundation, Madrid, Spain.Eline Verwer received research funding from the Society of Nuclear Medicine and Molecular Imaging Education and Research Foundation (Cassen Postdoctoral Mentoring Award to MDN).Sally Ji Who Kim received research funding from NIH T32 EB013180.Cinthya Agüero received research funding from the International Health Central America Institute, San Jose, Costa Rica.Marc D. Normandin received research funding from NIH National Institute of Neurological Disorders and Stroke (U01NS086659) and NIH National Institute of Mental Health (R01MH100350).Stephen N. Gomperts received research funding from NIH National Institute for Neurological Disorders and Stroke (R21 NS090243), the National Parkinson’s Foundation, and the Michael J. Fox Foundation for Parkinson’s Research.Keith A. Johnson received research funding from NIH (grants R01 EB014894, R21 AG038994, R01 AG026484, R01 AG034556, P50 AG00513421, U19 AG10483, P01 AG036694, R13 AG042201174210, R01 AG027435 and R01 AG037497) and the Alzheimer’s Association (ZEN-10-174,210 K). Keith A. Johnson has served as paid consultant for Bayer, GE Healthcare, Janssen Alzheimer’s Immunotherapy, Siemens Medical Solutions, Genzyme, Novartis, Biogen, Roche, ISIS Pharma, AZTherapy, GEHC, Lundberg, and Abbvie. He is a site co-investigator for Lilly/Avid, Janssen Immunotherapy and Pfizer.Matthew P. Frosch received research funding from the Massachusetts Alzheimer’s Disease Research Center (NIH AG005134).Teresa Gómez-Isla received research funding from NIH National Institute on Aging (AG005134 and AG036694).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
